A randomized, double-blind, placebo-controlled, dose-escalation Phase I clinical study evaluating effect of ophthalmic drug used to delay the progression of myopia in children, GPN00884 in China

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 02 Dec 2024

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

02 Dec 2024 New trial record
18 Nov 2024 According to Grand Pharma media release, this trial was approved to conduct Phase I clinical study in China in March 2024.
11 Jun 2024 According to Grand Pharma media release, this trial Has Completed the First Patient Enrollment

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com